Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 67

Cited In for PubMed (Select 8134899)

1.

Stroke modifies drug consumption in opium addicts: role of the insula.

Yousefzadeh-Fard Y, Gharedaghi MH, Esmaeili S, Pourbakhtyaran E, Sadaghiani MS, Ghorbani A, Sahraian MA.

Basic Clin Neurosci. 2013 Fall;4(4):307-14.

2.

Common effects of fat, ethanol, and nicotine on enkephalin in discrete areas of the brain.

Chang GQ, Karatayev O, Barson JR, Liang SC, Leibowitz SF.

Neuroscience. 2014 Sep 26;277:665-78. doi: 10.1016/j.neuroscience.2014.07.050. Epub 2014 Jul 30.

PMID:
25086310
3.

Dopamine receptor blockade modulates the rewarding and aversive properties of nicotine via dissociable neuronal activity patterns in the nucleus accumbens.

Sun N, Laviolette SR; Addiction Research Group.

Neuropsychopharmacology. 2014 Nov;39(12):2799-815. doi: 10.1038/npp.2014.130. Epub 2014 Jun 4.

PMID:
24896614
4.

Mechanisms of epigenetic memory and addiction.

Tuesta LM, Zhang Y.

EMBO J. 2014 May 16;33(10):1091-103. doi: 10.1002/embj.201488106. Epub 2014 Apr 28. Review.

PMID:
24778453
5.

Separating analgesia from reward within the ventral tegmental area.

Schifirneţ E, Bowen SE, Borszcz GS.

Neuroscience. 2014 Mar 28;263:72-87. doi: 10.1016/j.neuroscience.2014.01.009. Epub 2014 Jan 13.

6.

Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.

Mello NK, Fivel PA, Kohut SJ, Carroll FI.

Neuropsychopharmacology. 2014 Apr;39(5):1222-31. doi: 10.1038/npp.2013.325. Epub 2013 Nov 22.

7.

Smoking behaviour and mental health disorders--mutual influences and implications for therapy.

Minichino A, Bersani FS, Calò WK, Spagnoli F, Francesconi M, Vicinanza R, Delle Chiaie R, Biondi M.

Int J Environ Res Public Health. 2013 Oct 10;10(10):4790-811. doi: 10.3390/ijerph10104790. Review.

8.

Baseline impulsive choice predicts the effects of nicotine and nicotine withdrawal on impulsivity in rats.

Kayir H, Semenova S, Markou A.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:6-13. doi: 10.1016/j.pnpbp.2013.09.007. Epub 2013 Sep 20.

9.

Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine.

Navarrete F, Rodríguez-Arias M, Martín-García E, Navarro D, García-Gutiérrez MS, Aguilar MA, Aracil-Fernández A, Berbel P, Miñarro J, Maldonado R, Manzanares J.

Neuropsychopharmacology. 2013 Nov;38(12):2515-24. doi: 10.1038/npp.2013.157. Epub 2013 Jul 2.

10.

Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking.

Cohen A, George O.

Front Psychiatry. 2013 Jun 4;4:41. doi: 10.3389/fpsyt.2013.00041. eCollection 2013.

11.

Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation.

Li X, Semenova S, D'Souza MS, Stoker AK, Markou A.

Neuropharmacology. 2014 Jan;76 Pt B:554-65. doi: 10.1016/j.neuropharm.2013.05.042. Epub 2013 Jun 7. Review.

12.

Selective breeding for high alcohol preference increases the sensitivity of the posterior VTA to the reinforcing effects of nicotine.

Hauser SR, Bracken AL, Deehan GA Jr, Toalston JE, Ding ZM, Truitt WA, Bell RL, McBride WJ, Rodd ZA.

Addict Biol. 2014 Sep;19(5):800-11. doi: 10.1111/adb.12048. Epub 2013 Mar 18.

PMID:
23496648
13.

Effects of chronic buspirone treatment on nicotine and concurrent nicotine+cocaine self-administration.

Mello NK, Fivel PA, Kohut SJ.

Neuropsychopharmacology. 2013 Jun;38(7):1264-75. doi: 10.1038/npp.2013.25. Epub 2013 Jan 21.

14.

Rate dependent effects of acute nicotine on risk taking in young adults are not related to ADHD diagnosis.

Ryan KK, Dube SL, Potter AS.

Pharmacol Biochem Behav. 2013 Jan;103(3):652-8. doi: 10.1016/j.pbb.2012.11.005. Epub 2012 Nov 15.

15.

Glutamatergic and GABAergic metabolism in mouse brain under chronic nicotine exposure: implications for addiction.

Shameem M, Patel AB.

PLoS One. 2012;7(7):e41824. doi: 10.1371/journal.pone.0041824. Epub 2012 Jul 25.

16.

Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.

Panlilio LV, Justinova Z, Mascia P, Pistis M, Luchicchi A, Lecca S, Barnes C, Redhi GH, Adair J, Heishman SJ, Yasar S, Aliczki M, Haller J, Goldberg SR.

Neuropsychopharmacology. 2012 Jul;37(8):1838-47. doi: 10.1038/npp.2012.31. Epub 2012 Mar 28.

17.

Repeated exposure of the posterior ventral tegmental area to nicotine increases the sensitivity of local dopamine neurons to the stimulating effects of ethanol.

Ding ZM, Katner SN, Rodd ZA, Truitt W, Hauser SR, Deehan GA Jr, Engleman EA, McBride WJ.

Alcohol. 2012 May;46(3):217-23. doi: 10.1016/j.alcohol.2011.11.007. Epub 2012 Mar 25.

18.

Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Gold AB, Lerman C.

Hum Genet. 2012 Jan 31. [Epub ahead of print]

19.

Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies.

Engelmann JM, Versace F, Robinson JD, Minnix JA, Lam CY, Cui Y, Brown VL, Cinciripini PM.

Neuroimage. 2012 Mar;60(1):252-62. doi: 10.1016/j.neuroimage.2011.12.024. Epub 2011 Dec 21.

20.

Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Hurley LL, Taylor RE, Tizabi Y.

Neurotox Res. 2012 Jan;21(1):57-69. doi: 10.1007/s12640-011-9275-6. Epub 2011 Sep 20. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk